Allograft Articles & Analysis
26 news found
Insights into this paradigm are expected to link the regulation of pathways to the restoration of immune homeostasis for the treatment of a wide range of diseases, including infectious diseases, autoimmune disorders, allograft rejection and malignancies. To help scientists better understand the regulation and role of mTOR in metabolic regulation and to address some of the major ...
” OSSIOfiber Intelligent Bone Regeneration Technology is a breakthrough in fixation material that provides the first credible solution to the shortcomings of permanent metal hardware, conventional resorbable and allograft implants, and combines unparalleled mechanical strength and natural bone healing in a non-permanent implant. ...
Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and cell-based therapies, announced today the launch of Influx™ Fibrant, an unprecedented line of functional constructs derived from 100% cortical allograft. The cutting-edge line consisting of five new products includes Fibrant Anchor, Boat, Bullet, Pak and Wrap. The Fibrant launch ...
One patient developed de novo donor-specific antibodies; these antibodies were not found to be directed against posoleucel antigens in the matching cell line. Overall kidney allograft function, as assessed by creatinine and estimated glomerular filtration rate, remained stable. ...
ByKalaris
The data demonstrate that elderly patients in Denmark treated with i-FACTOR bone graft plus local bone had a statistically significantly higher fusion rate compared to allograft plus local bone. “In Scandinavia, surgeons often consider performing non-instrumented fusion when there is instability in elderly patients, but allograft bone has notoriously low ...
i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation. About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the only biologic bone graft in orthopedics that ...
Surgiliogix announces its new SXDBM Fiber allograft made of 100% demineralized cortical bone with no carrier. 100% demineralized cortical bone, when hydrated with any bioactive agent, creates a malleable fibrous structure for use in bony voids or gaps. ...
Axogen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance® Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector®, a porcine submucosa extracellular matrix (ECM) ...
Axogen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance® Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector®, a porcine submucosa extracellular matrix (ECM) ...
” Presentations featuring Axogen technologies include: “Histological Comparison of the Fascicular Area of Cabled Sural Nerve Autograft and Processed Nerve Allograft” selected for presentation at the AAHS/ASPN/ASRM Outstanding Paper Session on Saturday January 15. ...
Chris’s nerves were then reconstructed and reconnected using donated nerve tissue (processed nerve allograft) to bridge the resulting nerve gaps and restore normal signals to his brain. ...
” About the NUsurface® Implant The NUsurface® Implant is a medial meniscus replacement implant designed for patients with persistent knee pain following medial meniscus surgery, or those that have failed meniscus repair, are not suitable candidates for meniscus allograft transplant, or are too young for partial or total knee replacement. ...
Axogen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance® Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector®, a porcine submucosa extracellular matrix (ECM) ...
Axogen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance® Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector®, a porcine submucosa extracellular matrix (ECM) ...
TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue allografts to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions, announced today that they had completed a new round of hiring for their two commercial subsidiaries Bio-Tissue and Amniox Medical. ...
Bio-Tissue, Inc., a TissueTech company and pioneer in the clinical application of human birth tissue allografts to promote regenerative healing for ocular surface disease and disorders, announced today that it has entered into a Vendor Agreement with EyePro Group Purchasing Organization (GPO), LLC. ...
i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation. About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the only biologic bone graft in orthopedics that ...
Additionally, premium licensing of two important biologics from Cellularity – BIOVANCE® Human Amniotic Membrane Allograft and Interfyl® Human Connective Tissue Matrix – add to a portfolio of solutions that improve clinical outcomes across the continuum of wound care. ...
The study demonstrated high stability of urinary exosomes and reliability in monitoring patients for allograft rejection. The assay discriminates between “any-cause rejection vs. no rejection” with a negative predictive value (NPV) of 93.3% and positive predictive value (PPV) of 86.2% and differentiates between “T-cell mediated rejection (TCMR) vs. antibody ...
The BioAesthetics® NACgraft™ biologic matrix is a decellularized skin allograft of the human nipple-areolar complex (NAC) intended to replace the NAC when lost due to mastectomy or other procedure. ...